128 related articles for article (PubMed ID: 21810967)
1. Absorption and disposition of scutellarin in rats: a pharmacokinetic explanation for the high exposure of its isomeric metabolite.
Gao C; Chen X; Zhong D
Drug Metab Dispos; 2011 Nov; 39(11):2034-44. PubMed ID: 21810967
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic studies on the absorption and disposition of scutellarin in humans: selective OATP2B1-mediated hepatic uptake is a likely key determinant for its unique pharmacokinetic characteristics.
Gao C; Zhang H; Guo Z; You T; Chen X; Zhong D
Drug Metab Dispos; 2012 Oct; 40(10):2009-20. PubMed ID: 22822035
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration.
Chen X; Cui L; Duan X; Ma B; Zhong D
Drug Metab Dispos; 2006 Aug; 34(8):1345-52. PubMed ID: 16714374
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces.
Xing JF; You HS; Dong YL; Lu J; Chen SY; Zhu HF; Dong Q; Wang MY; Dong WH
Acta Pharmacol Sin; 2011 May; 32(5):655-63. PubMed ID: 21516133
[TBL] [Abstract][Full Text] [Related]
5. Two major urinary metabolites of scutellarin in rats.
Qiu F; Xia H; Zhang T; Di X; Qu G; Yao X
Planta Med; 2007 Apr; 73(4):363-5. PubMed ID: 17354170
[TBL] [Abstract][Full Text] [Related]
6. Influence of the gastrointestinal microflora and efflux transporters on the absorption of scutellarin and scutellarein.
You HS; Xing JF; Lu J; Dong WH; Liu JT; Dong YL
Phytother Res; 2014 Sep; 28(9):1295-300. PubMed ID: 24504668
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats.
Huang JM; Weng WY; Huang XB; Ji YH; Chen E
Eur J Drug Metab Pharmacokinet; 2005; 30(3):165-70. PubMed ID: 16250252
[TBL] [Abstract][Full Text] [Related]
8. Prodrugs of scutellarin: ethyl, benzyl and N,N-diethylglycolamide ester synthesis, physicochemical properties, intestinal metabolism and oral bioavailability in the rats.
Cao F; Guo JX; Ping QN; Liao ZG
Eur J Pharm Sci; 2006 Dec; 29(5):385-93. PubMed ID: 16997537
[TBL] [Abstract][Full Text] [Related]
9. Intestinal transport of scutellarein and scutellarin and first-pass metabolism by UDP-glucuronosyltransferase-mediated glucuronidation of scutellarein and hydrolysis of scutellarin.
Wang Y; Ao H; Qian Z; Zheng Y
Xenobiotica; 2011 Jul; 41(7):538-48. PubMed ID: 21561321
[TBL] [Abstract][Full Text] [Related]
10. β-Glucuronidase- and OATP2B1-mediated drug interaction of scutellarin in Dengzhan Xixin Injection: A formulation aspect.
Shi J; Sun C; Huang H; Lin W; Gao J; Lin Y; Zhang Z; Huo X; Tian X; Yu Z; Zhang B; Ma X
Drug Dev Res; 2020 Aug; 81(5):609-619. PubMed ID: 32220026
[TBL] [Abstract][Full Text] [Related]
11. Study on the role of hepatic first-pass elimination in the low oral bioavailability of scutellarin in rats.
Hao X; Cheng G; Yu JE; He Y; An F; Sun J; Cui F
Pharmazie; 2005 Jun; 60(6):477-8. PubMed ID: 15997843
[TBL] [Abstract][Full Text] [Related]
12. Determination of aglycone conjugated metabolites of scutellarin in rat plasma by HPLC.
Huang J; Li N; Yu Y; Weng W; Huang X
J Pharm Biomed Anal; 2006 Feb; 40(2):465-71. PubMed ID: 16181763
[TBL] [Abstract][Full Text] [Related]
13. Nanosuspension development of scutellarein as an active and rapid orally absorbed precursor of its BCS class IV glycoside scutellarin.
Yang X; Miao X; Cao F; Li S; Ai N; Chang Q; Lee SMY; Zheng Y
J Pharm Sci; 2014 Nov; 103(11):3576-3584. PubMed ID: 25187229
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary delivery of scutellarin solution and mucoadhesive particles in rats.
Liu XB; Ye JX; Quan LH; Liu CY; Deng XL; Yang M; Liao YH
Eur J Pharm Biopharm; 2008 Nov; 70(3):845-52. PubMed ID: 18675905
[TBL] [Abstract][Full Text] [Related]
15. [Effect of pravastatin on transportation of scutellarin in mouse liver and its mechanism].
Liu JM; Xiong YQ
Yao Xue Xue Bao; 2011 Mar; 46(3):269-73. PubMed ID: 21626779
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interaction between scutellarin and valsartan in rats.
Cui MY; Tian CC; Ju AX; Zhang CT; Li QH
Yao Xue Xue Bao; 2013 Apr; 48(4):541-6. PubMed ID: 23833943
[TBL] [Abstract][Full Text] [Related]
17. [Absorption and transportation characteristics of scutellarin and scutellarein across Caco-2 monolayer model].
You HS; Zhang HF; Dong YL; Chen SY; Wang MY; Dong WH; Xing JF
Zhong Xi Yi Jie He Xue Bao; 2010 Sep; 8(9):863-9. PubMed ID: 20836977
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic and tissue distribution study of scutellarin in rats].
You HS; Dong YL; Xing JF; Zhang CL; Wang MY
Zhongguo Zhong Yao Za Zhi; 2007 Aug; 32(16):1688-92. PubMed ID: 18027669
[TBL] [Abstract][Full Text] [Related]
19. Mrp2-related efflux of scutellarin in the intestinal absorption in rats.
Cao F; Zhang H; Guo J; Ping Q
Pharmazie; 2008 Jan; 63(1):75-80. PubMed ID: 18271309
[TBL] [Abstract][Full Text] [Related]
20. Metabolism profile of scutellarin in urine following oral administration to rats by ultra performance liquid chromatography coupled to time-of-flight mass spectrometry.
Liu Q; Shi Y; Wang Y; Lu J; Cong W; Luo G; Wang Y
Talanta; 2009 Nov; 80(1):84-91. PubMed ID: 19782195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
